JP2005516996A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516996A5
JP2005516996A5 JP2003565503A JP2003565503A JP2005516996A5 JP 2005516996 A5 JP2005516996 A5 JP 2005516996A5 JP 2003565503 A JP2003565503 A JP 2003565503A JP 2003565503 A JP2003565503 A JP 2003565503A JP 2005516996 A5 JP2005516996 A5 JP 2005516996A5
Authority
JP
Japan
Prior art keywords
residue
xaa
pharmaceutical composition
threonine
serine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003565503A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516996A (ja
Filing date
Publication date
Priority claimed from US10/072,419 external-priority patent/US6852693B2/en
Application filed filed Critical
Publication of JP2005516996A publication Critical patent/JP2005516996A/ja
Publication of JP2005516996A5 publication Critical patent/JP2005516996A5/ja
Withdrawn legal-status Critical Current

Links

JP2003565503A 2002-02-07 2003-02-07 脂質可動化、グリコーゲン可動化、またはその両方をヒトにおいて促進するための組成物および方法 Withdrawn JP2005516996A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/072,419 US6852693B2 (en) 2002-02-07 2002-02-07 Compositions and methods for promoting lipid mobilization in humans
PCT/US2003/003800 WO2003066080A1 (en) 2002-02-07 2003-02-07 Compositions and methods for promoting lipid mobilization, glycogen mobilization, or both, in humans

Publications (2)

Publication Number Publication Date
JP2005516996A JP2005516996A (ja) 2005-06-09
JP2005516996A5 true JP2005516996A5 (enExample) 2006-03-30

Family

ID=27732307

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003565503A Withdrawn JP2005516996A (ja) 2002-02-07 2003-02-07 脂質可動化、グリコーゲン可動化、またはその両方をヒトにおいて促進するための組成物および方法

Country Status (7)

Country Link
US (3) US6852693B2 (enExample)
EP (1) EP1480668A1 (enExample)
JP (1) JP2005516996A (enExample)
AU (1) AU2003210923A1 (enExample)
CA (1) CA2474203A1 (enExample)
WO (1) WO2003066080A1 (enExample)
ZA (1) ZA200406715B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852693B2 (en) * 2002-02-07 2005-02-08 Blm Group Compositions and methods for promoting lipid mobilization in humans
WO2005067912A1 (en) * 2004-01-02 2005-07-28 Washington University In St. Louis Method of intentionally, noninvasively, therapeutically modulating fat in a living mammal
US20050222040A1 (en) * 2004-04-05 2005-10-06 Blm Group, Inc. Vertebrate peptide modulators of lipid metabolism
JP4688483B2 (ja) * 2004-04-15 2011-05-25 株式会社テクノネットワーク四国 フォリスタチン変異体ポリペプチド
WO2010051347A1 (en) * 2008-10-31 2010-05-06 David Sheikh-Hamad A method for cardioprotection
CN102438580B (zh) * 2009-02-06 2015-06-17 加利福尼亚大学董事会 钙结合剂诱导毛发生长和/或甲生长
EP3119416B1 (en) 2015-03-26 2017-12-20 Mutlu, Oguz Therapeutic use of adipokinetic hormone/red pigment-concentrating hormone (akh/rpch) family of peptides
TR201712479A2 (tr) 2017-08-22 2019-05-21 Oguz Mutlu Adi̇poki̇neti̇k hormon/kirmizi pi̇gment-konsantre edi̇ci̇ hormon (akh/rpch) pepti̇t ai̇lesi̇ni̇n yeni̇ terapöti̇k kullanimlari
KR102380291B1 (ko) * 2020-06-15 2022-03-29 대한민국 풀무치 추출물을 포함하는 비만 예방 또는 치료용 조성물
KR102380290B1 (ko) * 2020-06-15 2022-03-29 대한민국 아메리카왕거저리 유충 추출물을 포함하는 비만 예방 또는 치료용 조성물
GB202215797D0 (en) 2022-10-25 2022-12-07 Solasta Bio Ltd Insect neuropeptide analogues
US12245588B1 (en) 2023-10-23 2025-03-11 Solasta Bio Limited Insect neuropeptides 2
US12356995B2 (en) 2023-10-23 2025-07-15 Solasta Bio Limited Insect neuropeptides 9
US12281143B1 (en) 2023-10-23 2025-04-22 Solasta Bio Limited Insect neuropeptides 1
US12302908B2 (en) 2023-10-23 2025-05-20 Solasta Bio Limited Insect neuropeptides 4
US12245596B1 (en) 2023-10-23 2025-03-11 Solasta Bio Limited Insect neuropeptides 8
EP4570072A3 (en) * 2023-10-23 2025-07-02 Solasta Bio Limited Insect neuropeptides 8
US12279621B1 (en) 2023-10-23 2025-04-22 Solasta Bio Limited Insect neuropeptides 3

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260601A (en) 1979-10-23 1981-04-07 Nyegaard & Co. A/S Chemical compounds
US4328134A (en) 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4464356A (en) 1982-05-07 1984-08-07 Mordes John P Anorexigenic composition and method
US4489059A (en) 1982-05-07 1984-12-18 Rossini Aldo A Anorexigenic composition and method
US4891219A (en) 1986-03-14 1990-01-02 Aphton Corporation Method for immunization against and treatment of infection by ectoparasites and endoparasites
GB8806471D0 (en) 1988-03-18 1988-04-20 Tisdale M J Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
FR2710340B1 (fr) 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
US6852693B2 (en) * 2002-02-07 2005-02-08 Blm Group Compositions and methods for promoting lipid mobilization in humans

Similar Documents

Publication Publication Date Title
JP2005516996A5 (enExample)
JP2005505579A5 (enExample)
ES2302390T3 (es) Analogos de glp-1.
JP2003501022A5 (enExample)
JPH05163298A (ja) 新規ポリペプチドおよびこれを用いる抗hiv剤
JP2005519059A5 (enExample)
JP2007001987A5 (enExample)
JP2011511753A5 (enExample)
RU2010103995A (ru) Бифункциональные слитые белки альфа-меланоцитостимулирующего гормона (альф-msh) и атриального натрийуретического белка (anp) и их применение при гипертонии и остром повреждении почек
RU2016120641A (ru) Новые полипептиды
WO2008039483A3 (en) Modified self-assembling peptides
JP2010510315A5 (enExample)
PT1290013E (pt) Derivados dos peptidos apo-ai/aii
JP2004521123A5 (enExample)
CN1096515A (zh) 新型肽
JP2006514820A5 (enExample)
JP2004505640A5 (enExample)
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
JP2006503088A5 (enExample)
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
WO2002068608A3 (en) Sulfated ccr5 peptides for hiv-1 infection
JP2003522185A5 (enExample)
JP2008517998A5 (enExample)
MY113407A (en) Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
JP2006507328A5 (enExample)